Table 1 Relationships between the H-Score of SULF1 and clinicopathologic characteristics in 80 gastric cancer patients.
Characteristics | Group | Case | H-Score of SULF1 | p value | |
|---|---|---|---|---|---|
Low | High | ||||
Age | <60 | 39 | 22 (27.5%) | 17 (21.2%) | 0.263 |
≥60 | 41 | 18 (22.5%) | 23 (28.7%) | ||
Gender | Male | 49 | 23 (28.7%) | 26 (32.5%) | 0.491 |
Female | 31 | 17 (21.2%) | 14 (17.5%) | ||
Tumor size | <4 cm | 46 | 29 (36.2%) | 17 (21.2%) | 0.007 |
≥4 cm | 34 | 11 (13.8%) | 23 (28.7%) | ||
Tumor differentiation | Well + moderate | 53 | 31 (38.8%) | 22 (27.5%) | 0.033 |
Poor | 27 | 9 (11.2%) | 18 (22.5%) | ||
Tumor Invasion | T1–T2 | 29 | 20 (25%) | 9 (11.2%) | 0.011 |
T3–T4 | 51 | 20 (25%) | 31 (38.8%) | ||
Lymph node metastasis | Negative | 29 | 22 (27.5%) | 7 (8.8%) | <0.001 |
Positive | 51 | 18 (22.5%) | 33 (41.2%) | ||
TNM stage | I–II | 33 | 22 (27.5%) | 11 (13.8%) | 0.012 |
III–IV | 47 | 18 (22.5%) | 29 (36.2%) | ||
